Rafael Guardia-La
Granada, AN 18016, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Engraftment characterization of risk-stratified AML in NSGS mice.
Journal: Blood advances
Published: December 07, 2020
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo.
Journal: Journal for immunotherapy of cancer
Published: May 07, 2020
Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells.
Journal: Molecular therapy. Nucleic acids
Published: October 07, 2019
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.
Journal: Leukemia
Published: September 20, 2018
Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment.
Journal: Nucleic acids research
Published: June 29, 2018
IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML.
Journal: Oncoimmunology
Published: January 08, 2018
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
Journal: Stem cell reports
Published: January 13, 2017
Proinflammatory signals are insufficient to drive definitive hematopoietic specification of human HSCs in vitro.
Journal: Experimental hematology
Published: August 28, 2016
Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease.
Journal: Experimental & molecular medicine
Published: July 14, 2016
Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase.
Journal: Arthritis research & therapy
Published: November 02, 2015
Last Updated: 09/26/2026